Proxima: Valuation, Funding & Investors
Proxima is an AI-native biotechnology company focused on discovery and development of proximity-based therapeutics that modulate protein-protein interactions. The company combines proteome-scale structural proteomics and generative AI models to enable end-to-end discovery of proximity-modulating small molecules across oncology, immunology, and other disease areas.
Leadership & Board
- Current Number of Employees
- 75
- Current LinkedIn Followers
- 12,691
Latest Estimated Valuation
- Total Amount Raised
- $80M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $80M
- Latest Funding Round
- Seed Round
Employee Trend
Proxima had 75 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
75Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Proxima had 12,691 followers as of November 9, 2026. The number of followers increased by 37 (0.29%) week-over-week.
12,691Latest Followers Count
37(0.29%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 13, 2026 | Seed Round | $80.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| DCVC | Seed Round |
| Alexandria Venture Investments | Seed Round |
| Yosemite | Seed Round |
| AIX Ventures | Seed Round |
| NVentures | Seed Round |
| Magnetic Ventures | Seed Round |
| Roivant | Seed Round |
| Braidwell | Seed Round |
Similar Companies
A snapshot of private companies similar to Proxima, helping you discover and navigate related company profiles.







